# Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking

Study · id `cardio:ct-nct05200052` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05200052](<https://clinicaltrials.gov/study/NCT05200052>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05200052

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05200052. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2022-08-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05200052, source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)
- Started: 2022-02-01 (actual) (ClinicalTrials.gov record NCT05200052, source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)
- Primary completion: 2022-08-01 (actual) (ClinicalTrials.gov record NCT05200052, source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)
- Completion: 2022-08-01 (actual) (ClinicalTrials.gov record NCT05200052, source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT05200052, source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05200052-2022-08-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking
- Condition: Anterior MI
- Condition: Colchicine
- Intervention (Drug): Colchicine 0.5 mg Oral Tablet
- Lead sponsor: Ain Shams University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Ain Shams University (`cardio:org-ain-shams-university`)

## Provenance

Content hash: a9cfdaed755ef1a4c5beeb6e93efbd0e33b84841010aca10ac7c958e6cd87b72
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
